首页> Cancer> Clinical and biological factors associated with response to immune checkpoint inhibitors in advanced sarcomas: IMPRESARC, a French retrospective multicenter cohort study.

Clinical and biological factors associated with response to immune checkpoint inhibitors in advanced sarcomas: IMPRESARC, a French retrospective multicenter cohort study.

导出 OA

翻译打印收藏纠错

第一作者： Mina,Fazel

第一单位： Department of Medical Oncology, Centre Léon Bérard, Lyon, France.;Faculté de Médecine Lyon Est, Université Claude Bernard Lyon, Lyon, France.

作者： Mina,Fazel ^[1] ; Romain,Varnier ^[1] ; Hélène,Vanacker ^[1] ; Nicolas,Penel ^[2] ; Sarah,Watson ^[3] ; Benjamin,Verret ^[4] ; Thibaud,Valentin ^[5] ; Emmanuelle,Bompas ^[6] ; Waisse,Waissi ^[1] ; Alexandra,Meurgey ^[7] ; Françoise,Ducimetière ^[8] ; Jean-Yves,Blay ^[1] ; Armelle,Dufresne ^[7] ; Mehdi,Brahmi ^[7]

作者单位： Department of Medical Oncology, Centre Léon Bérard, Lyon, France.;Faculté de Médecine Lyon Est, Université Claude Bernard Lyon, Lyon, France. ^[1] Department of Medical Oncology, Centre Oscar-Lambret, Lille, France.;ULR 2694-Metrics: Évaluation des Technologies de Santé et des Pratiques Médicales, CHU de Lille, University of Lille, Lille, France. ^[2] Department of Medical Oncology, Institut Curie, Paris, France.;INSERM U830, Institut Curie, Paris, France. ^[3] Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France.;INSERM U981, Institut Gustave Roussy, Villejuif, France. ^[4] Department of Medical Oncology, IUCT-Oncopole, Toulouse, France. ^[5] Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Nantes, France. ^[6] Department of Medical Oncology, Centre Léon Bérard, Lyon, France. ^[7] NETSARC+ Transversal Task Force, Lyon, France. ^[8]

关键词 immune checkpoint inhibitor immunotherapy predictive factors sarcoma